{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:50:54Z","timestamp":1790887854499,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, China","award":["2022LSYS008"],"award-info":[{"award-number":["2022LSYS008"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32100513"],"award-info":[{"award-number":["32100513"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic and Applied Basic Research Foundation of Guangzhou, China","award":["SL2023A04J00291"],"award-info":[{"award-number":["SL2023A04J00291"]}]},{"name":"the Science and Technology Program of Guangzhou, China","award":["2024A04J3341"],"award-info":[{"award-number":["2024A04J3341"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aberrant alternative splicing (AS) contributes to cancer stemness and progression in hepatocellular carcinoma (HCC). However, the regulatory roles of long noncoding RNAs (lncRNAs) in linking AS dysregulation to tumor stemness remain elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed integrated bulk and single-cell RNA-Seq analyses combined with functional assays to identify key lncRNAs associated with splicing regulation and cancer stemness in HCC. Mechanistic studies were conducted to elucidate the molecular interplay between lncRNAs, splicing factors, and transcriptional regulators. Drug sensitivity assays were used to evaluate therapeutic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Global analysis revealed increased splicing regulator activity during hepatocellular carcinoma (HCC) progression, which correlated with poor prognosis. This splicing dysregulation led us to identify 28 lncRNAs that connect aberrant splicing with cancer stemness. Among these,\n                      <jats:italic>RAB30-DT<\/jats:italic>\n                      was significantly overexpressed in malignant epithelial cells and associated with advanced tumor stage, stemness features, genomic instability, and poor patient prognosis. Functional assays demonstrated that\n                      <jats:italic>RAB30-DT<\/jats:italic>\n                      promotes proliferation, migration, invasion, colony and sphere formation in vitro, and tumor growth in vivo. Mechanistically,\n                      <jats:italic>RAB30-DT<\/jats:italic>\n                      is transcriptionally activated by CREB1 and directly binds and stabilizes the splicing kinase SRPK1, facilitating its nuclear localization. This interaction broadly reshapes the AS landscape, including splicing of the cell cycle regulator CDCA7, to drive tumor stemness and malignancy. Importantly, pharmacological disruption of the CREB1\u2013RAB30-DT\u2013SRPK1 axis sensitizes HCC cells to targeted therapies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study reveals a novel lncRNA-mediated signaling axis that integrates transcriptional regulation and splicing reprogramming to sustain cancer stemness and progression in HCC. Targeting this axis offers promising therapeutic opportunities for HCC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03546-w","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:57:12Z","timestamp":1760014632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel lncRNA-mediated signaling axis governs cancer stemness and splicing reprogramming in hepatocellular carcinoma with therapeutic potential"],"prefix":"10.1186","volume":"44","author":[{"given":"Ke","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"6","key":"3546_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606.","journal-title":"J Hepatol"},{"key":"3546_CR2","doi-asserted-by":"crossref","unstructured":"Devan AR, Nair B, Aryan MK, Liju VB, Koshy JJ, Mathew B et al. Decoding immune signature to detect the risk for Early-Stage HCC recurrence. Cancers (Basel) 2023;15(10).","DOI":"10.3390\/cancers15102729"},{"issue":"10360","key":"3546_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"key":"3546_CR4","doi-asserted-by":"crossref","unstructured":"Zhao H, Ling Y, He J, Dong J, Mo Q, Wang Y et al. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma. Drug Resist Updat. 2024;74:101084.","DOI":"10.1016\/j.drup.2024.101084"},{"issue":"1","key":"3546_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","volume":"19","author":"TK Lee","year":"2022","unstructured":"Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19(1):26\u201344.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3546_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):8.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"3546_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molmed.2023.07.001","volume":"29","author":"K Xu","year":"2023","unstructured":"Xu K, Wu T, Xia P, Chen X, Yuan Y. Alternative splicing: a Bridge connecting NAFLD and HCC. Trends Mol Med. 2023;29(10):859\u201372.","journal-title":"Trends Mol Med"},{"issue":"19","key":"3546_CR8","doi-asserted-by":"publisher","first-page":"17691","DOI":"10.1007\/s00432-023-05474-8","volume":"149","author":"M Sheng","year":"2023","unstructured":"Sheng M, Zhang Y, Wang Y, Liu W, Wang X, Ke T, et al. Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review. J Cancer Res Clin Oncol. 2023;149(19):17691\u2013708.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"3546_CR9","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.18632\/aging.205523","volume":"16","author":"W Liang","year":"2024","unstructured":"Liang W, Zhao Y, Meng Q, Jiang W, Deng S, Xue J. The role of long non-coding RNA in hepatocellular carcinoma. Aging. 2024;16(4):4052\u201373.","journal-title":"Aging"},{"key":"3546_CR10","doi-asserted-by":"crossref","unstructured":"Vij P, Hussain MS, Satapathy SK, Cobos E, Tripathi MK. The emerging role of long noncoding RNAs in Sorafenib resistance within hepatocellular carcinoma. Cancers (Basel) 2024;16(23).","DOI":"10.3390\/cancers16233904"},{"issue":"8","key":"3546_CR11","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.7150\/thno.83920","volume":"13","author":"M Liu","year":"2023","unstructured":"Liu M, Zhang S, Zhou H, Hu X, Li J, Fu B, et al. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics. 2023;13(8):2616\u201331.","journal-title":"Theranostics"},{"issue":"8","key":"3546_CR12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41416-021-01600-w","volume":"126","author":"J Ouyang","year":"2022","unstructured":"Ouyang J, Zhong Y, Zhang Y, Yang L, Wu P, Hou X, et al. Long non-coding RNAs are involved in alternative splicing and promote cancer progression. Br J Cancer. 2022;126(8):1113\u201324.","journal-title":"Br J Cancer"},{"issue":"2","key":"3546_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/neuonc\/noaa156","volume":"23","author":"A Santangelo","year":"2021","unstructured":"Santangelo A, Rossato M, Lombardi G, Benfatto S, Lavezzari D, De Salvo GL, et al. A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib. Neuro Oncol. 2021;23(2):264\u201376.","journal-title":"Neuro Oncol"},{"issue":"7","key":"3546_CR14","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.4251\/wjgo.v16.i7.3082","volume":"16","author":"HQ Shi","year":"2024","unstructured":"Shi HQ, Huang S, Ma XY, Tan ZJ, Luo R, Luo B, et al. BCAR3 and BCAR3-related competing endogenous RNA expression in hepatocellular carcinoma and their prognostic value. World J Gastrointest Oncol. 2024;16(7):3082\u201396.","journal-title":"World J Gastrointest Oncol"},{"issue":"10","key":"3546_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Cancer Genome Atlas Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, et al. The cancer genome atlas Pan-Cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"key":"3546_CR16","doi-asserted-by":"crossref","unstructured":"Rodrigues KS, Petroski LP, Utumi PH, Ferrasa A, Herai RH. IARA: a complete and curated atlas of the biogenesis of spliceosome machinery during RNA splicing. Life Sci Alliance 2023;6(3).","DOI":"10.26508\/lsa.202201593"},{"issue":"1","key":"3546_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41597-023-02709-8","volume":"10","author":"S Gul","year":"2023","unstructured":"Gul S, Pang J, Yuan H, Chen Y, Yu Q, Wang H, et al. Stemness signature and targeted therapeutic drugs identification for triple negative breast cancer. Sci Data. 2023;10(1):815.","journal-title":"Sci Data"},{"issue":"1","key":"3546_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7150\/ijbs.66913","volume":"18","author":"D Chen","year":"2022","unstructured":"Chen D, Liu J, Zang L, Xiao T, Zhang X, Li Z, et al. Integrated machine learning and bioinformatic analyses constructed a novel Stemness-Related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients. Int J Biol Sci. 2022;18(1):360\u201373.","journal-title":"Int J Biol Sci"},{"key":"3546_CR19","doi-asserted-by":"crossref","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","DOI":"10.1186\/1471-2105-12-77"},{"issue":"1","key":"3546_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"GQ Zhu","year":"2023","unstructured":"Zhu GQ, Tang Z, Huang R, Qu WF, Fang Y, Yang R, et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 2023;9(1):25.","journal-title":"Cell Discov"},{"issue":"12","key":"3546_CR21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"key":"3546_CR22","doi-asserted-by":"crossref","unstructured":"Becht E, McInnes L, Healy J, Dutertre CA, Kwok IWH, Ng LG et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol 2018.","DOI":"10.1038\/nbt.4314"},{"issue":"6476","key":"3546_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, Sikandar SS, Wesche DJ, Manjunath A, Bharadwaj A, Berger MJ, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367(6476):405\u201311.","journal-title":"Science"},{"issue":"4","key":"3546_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"17","key":"3546_CR25","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884\u201390.","journal-title":"Bioinformatics"},{"issue":"1","key":"3546_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"16","key":"3546_CR27","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence Alignment\/Map format and samtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"key":"3546_CR28","doi-asserted-by":"crossref","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","DOI":"10.1186\/1471-2105-12-323"},{"issue":"7","key":"3546_CR29","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3546_CR30","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterprofiler to characterize multiomics data. Nat Protoc. 2024;19(11):3292\u2013320.","journal-title":"Nat Protoc"},{"issue":"51","key":"3546_CR31","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci U S A. 2014;111(51):E5593\u2013601.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3546_CR32","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/prot.26578","volume":"91","author":"J Sarzynska","year":"2023","unstructured":"Sarzynska J, Popenda M, Antczak M, Szachniuk M. RNA tertiary structure prediction using RNAComposer in CASP15. Proteins. 2023;91(12):1790\u20139.","journal-title":"Proteins"},{"issue":"14","key":"3546_CR33","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/nar\/gks339","volume":"40","author":"M Popenda","year":"2012","unstructured":"Popenda M, Szachniuk M, Antczak M, Purzycka KJ, Lukasiak P, Bartol N, et al. Automated 3D structure composition for large RNAs. Nucleic Acids Res. 2012;40(14):e112.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3546_CR34","doi-asserted-by":"publisher","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","volume":"51","author":"SK Burley","year":"2023","unstructured":"Burley SK, Bhikadiya C, Bi C, Bittrich S, Chao H, Chen L, et al. RCSB protein data bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning. Nucleic Acids Res. 2023;51(D1):D488\u2013508.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3546_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13046-025-03465-w","volume":"44","author":"L Zhao","year":"2025","unstructured":"Zhao L, Si K, Luo S, Zhang L, Mao S, Zhang W. Non-canonical activation of MAPK signaling by the LncRNA ASH1L-AS1-encoded microprotein APPLE through Inhibition of PP1\/PP2A-mediated ERK1\/2 dephosphorylation in hepatocellular carcinoma. J Exp Clin Cancer Res. 2025;44(1):200.","journal-title":"J Exp Clin Cancer Res"},{"key":"3546_CR36","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 2021;22(6).","DOI":"10.1093\/bib\/bbab260"},{"issue":"2","key":"3546_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nchembio.1986","volume":"12","author":"MG Rees","year":"2016","unstructured":"Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12(2):109\u201316.","journal-title":"Nat Chem Biol"},{"issue":"16","key":"3546_CR38","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.bmcl.2019.06.006","volume":"29","author":"MV Kozlov","year":"2019","unstructured":"Kozlov MV, Konduktorov KA, Shcherbakova AS, Kochetkov SN. Synthesis of N\u2019-propylhydrazide analogs of hydroxamic inhibitors of histone deacetylases (HDACs) and evaluation of their impact on activities of HDACs and replication of hepatitis C virus (HCV). Bioorg Med Chem Lett. 2019;29(16):2369\u201374.","journal-title":"Bioorg Med Chem Lett"},{"issue":"19","key":"3546_CR39","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1021\/acs.jmedchem.7b00467","volume":"60","author":"G Dong","year":"2017","unstructured":"Dong G, Chen W, Wang X, Yang X, Xu T, Wang P, et al. Small molecule inhibitors simultaneously targeting cancer metabolism and epigenetics: discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) and histone deacetylase (HDAC) dual inhibitors. J Med Chem. 2017;60(19):7965\u201383.","journal-title":"J Med Chem"},{"issue":"7","key":"3546_CR40","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1535-7163.MCT-10-0037","volume":"9","author":"EB Garon","year":"2010","unstructured":"Garon EB, Finn RS, Hosmer W, Dering J, Ginther C, Adhami S, et al. Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines. Mol Cancer Ther. 2010;9(7):1985\u201394.","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"3546_CR41","doi-asserted-by":"publisher","first-page":"9788","DOI":"10.1021\/acs.jmedchem.6b00943","volume":"59","author":"CH Zhang","year":"2016","unstructured":"Zhang CH, Chen K, Jiao Y, Li LL, Li YP, Zhang RJ, et al. From lead to drug candidate: optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine derivatives as agents for the treatment of triple negative breast cancer. J Med Chem. 2016;59(21):9788\u2013805.","journal-title":"J Med Chem"},{"key":"3546_CR42","doi-asserted-by":"crossref","unstructured":"Gabbia D, De Martin S. Tumor mutational burden for predicting prognosis and therapy outcome of hepatocellular carcinoma. Int J Mol Sci 2023;24(4).","DOI":"10.3390\/ijms24043441"},{"key":"3546_CR43","doi-asserted-by":"crossref","unstructured":"Zhang Q, Liu L. Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough. Cancer Lett. 2024;587:216691.","DOI":"10.1016\/j.canlet.2024.216691"},{"issue":"D1","key":"3546_CR44","doi-asserted-by":"publisher","first-page":"D413","DOI":"10.1093\/nar\/gkab847","volume":"50","author":"D Lv","year":"2022","unstructured":"Lv D, Chang Z, Cai Y, Li J, Wang L, Jiang Q, et al. TransLnc: a comprehensive resource for translatable LncRNAs extends immunopeptidome. Nucleic Acids Res. 2022;50(D1):D413\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3546_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13046-022-02401-6","volume":"41","author":"B Liu","year":"2022","unstructured":"Liu B, Fang X, Kwong DL, Zhang Y, Verhoeft K, Gong L, et al. Targeting TROY-mediated P85a\/AKT\/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41(1):182.","journal-title":"J Exp Clin Cancer Res"},{"issue":"17","key":"3546_CR46","doi-asserted-by":"publisher","first-page":"10194","DOI":"10.1093\/nar\/gkae677","volume":"52","author":"A Shinkai","year":"2024","unstructured":"Shinkai A, Hashimoto H, Shimura C, Fujimoto H, Fukuda K, Horikoshi N, et al. The C-terminal 4CXXC-type zinc finger domain of CDCA7 recognizes hemimethylated DNA and modulates activities of chromatin remodeling enzyme HELLS. Nucleic Acids Res. 2024;52(17):10194\u2013219.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"3546_CR47","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1084\/jem.20131857","volume":"211","author":"J Guiu","year":"2014","unstructured":"Guiu J, Bergen DJ, De Pater E, Islam AB, Ayllon V, Gama-Norton L, et al. Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence. J Exp Med. 2014;211(12):2411\u201323.","journal-title":"J Exp Med"},{"issue":"1","key":"3546_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41419-025-07399-1","volume":"16","author":"D Zheng","year":"2025","unstructured":"Zheng D, Deng Y, Deng L, He Z, Sun X, Gong Y, et al. CDCA7 enhances STAT3 transcriptional activity to regulate aerobic Glycolysis and promote pancreatic cancer progression and gemcitabine resistance. Cell Death Dis. 2025;16(1):68.","journal-title":"Cell Death Dis"},{"issue":"23","key":"3546_CR49","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137.","journal-title":"Cancer Res"},{"issue":"D1","key":"3546_CR50","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2024;52(D1):D174\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"3546_CR51","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41388-025-03284-5","volume":"44","author":"KF Man","year":"2025","unstructured":"Man KF, Darweesh O, Hong J, Thompson A, O\u2019Connor C, Bonaldo C, et al. CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance. Oncogene. 2025;44(16):1093\u2013105.","journal-title":"Oncogene"},{"issue":"3","key":"3546_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cac2.12403","volume":"43","author":"P Xia","year":"2023","unstructured":"Xia P, Zhang H, Lu H, Xu K, Jiang X, Jiang Y, et al. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Commun (Lond). 2023;43(3):338\u201364.","journal-title":"Cancer Commun (Lond)"},{"issue":"22","key":"3546_CR53","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1158\/0008-5472.CAN-22-1369","volume":"82","author":"T Fujishita","year":"2022","unstructured":"Fujishita T, Kojima Y, Kajino-Sakamoto R, Mishiro-Sato E, Shimizu Y, Hosoda W, et al. The cAMP\/PKA\/CREB and TGFbeta\/SMAD4 pathways regulate stemness and metastatic potential in colorectal cancer cells. Cancer Res. 2022;82(22):4179\u201390.","journal-title":"Cancer Res"},{"issue":"34","key":"3546_CR54","doi-asserted-by":"publisher","first-page":"eadp5753","DOI":"10.1126\/sciadv.adp5753","volume":"10","author":"IE Wassing","year":"2024","unstructured":"Wassing IE, Nishiyama A, Shikimachi R, Jia Q, Kikuchi A, Hiruta M, et al. CDCA7 is an evolutionarily conserved hemimethylated DNA sensor in eukaryotes. Sci Adv. 2024;10(34):eadp5753.","journal-title":"Sci Adv"},{"issue":"6","key":"3546_CR55","doi-asserted-by":"publisher","first-page":"eadk3384","DOI":"10.1126\/sciadv.adk3384","volume":"10","author":"M Vukic","year":"2024","unstructured":"Vukic M, Chouaref J, Della Chiara V, Dogan S, Ratner F, Hogenboom JZM, et al. CDCA7-associated global aberrant DNA hypomethylation translates to localized, tissue-specific transcriptional responses. Sci Adv. 2024;10(6):eadk3384.","journal-title":"Sci Adv"},{"key":"3546_CR56","doi-asserted-by":"crossref","unstructured":"Guo D, Du Z, Liu Y, Lin M, Lu Y, Hardikar S et al. The ZBTB24-CDCA7-HELLS axis suppresses the totipotent 2\u00a0C-like reprogramming by maintaining Dux methylation and repression. Nucleic Acids Res 2025;53(7).","DOI":"10.1093\/nar\/gkaf302"},{"issue":"1","key":"3546_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13277-015-3771-x","volume":"37","author":"J Zhang","year":"2016","unstructured":"Zhang J, Jiang H, Xia W, Jiang Y, Tan X, Liu P, et al. Serine-arginine protein kinase 1 is associated with hepatocellular carcinoma progression and poor patient survival. Tumour Biol. 2016;37(1):283\u201390.","journal-title":"Tumour Biol"},{"issue":"10","key":"3546_CR58","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s11010-022-04456-7","volume":"477","author":"WP Duggan","year":"2022","unstructured":"Duggan WP, O\u2019Connell E, Prehn JHM, Burke JP. Serine-Arginine protein kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis. Mol Cell Biochem. 2022;477(10):2451\u201367.","journal-title":"Mol Cell Biochem"},{"key":"3546_CR59","doi-asserted-by":"crossref","unstructured":"Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS. Serine-Arginine protein kinase 1 (SRPK1) as a prognostic factor and potential therapeutic target in cancer: current evidence and future perspectives. Cells 2019;9(1).","DOI":"10.3390\/cells9010019"},{"issue":"1","key":"3546_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-021-01877-y","volume":"40","author":"H Liu","year":"2021","unstructured":"Liu H, Gong Z, Li K, Zhang Q, Xu Z, Xu Y. SRPK1\/2 and PP1alpha exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma. J Exp Clin Cancer Res. 2021;40(1):75.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"3546_CR61","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1261\/rna.045583.114","volume":"20","author":"JC Lin","year":"2014","unstructured":"Lin JC, Lin CY, Tarn WY, Li FY. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events. RNA. 2014;20(10):1621\u201331.","journal-title":"RNA"},{"key":"3546_CR62","doi-asserted-by":"crossref","unstructured":"Wang Q, Wang GT, Lu WH. MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1. Technol Cancer Res Treat. 2021;20:1533033820957021.","DOI":"10.1177\/1533033820957021"},{"issue":"1","key":"3546_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-017-0675-y","volume":"16","author":"Q Xu","year":"2017","unstructured":"Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K\/AKT pathway. Mol Cancer. 2017;16(1):103.","journal-title":"Mol Cancer"},{"issue":"1\u20132","key":"3546_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-013-1641-7","volume":"379","author":"B Zhou","year":"2013","unstructured":"Zhou B, Li Y, Deng Q, Wang H, Wang Y, Cai B, et al. SRPK1 contributes to malignancy of hepatocellular carcinoma through a possible mechanism involving PI3K\/Akt. Mol Cell Biochem. 2013;379(1\u20132):191\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3546_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12935-021-02161-x","volume":"21","author":"XW Pan","year":"2021","unstructured":"Pan XW, Xu D, Chen WJ, Chen JX, Chen WJ, Ye JQ, et al. USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A(165b) alternative splicing via regulating SRSF1 and SRPK1. Cancer Cell Int. 2021;21(1):486.","journal-title":"Cancer Cell Int"},{"key":"3546_CR66","doi-asserted-by":"crossref","unstructured":"Mavrou A, Oltean S. SRPK1 Inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing. Pharmacol Res 2016;107(276\u2009\u2013\u200981.","DOI":"10.1016\/j.phrs.2016.03.013"},{"issue":"8","key":"3546_CR67","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1074\/jbc.M109.074930","volume":"285","author":"DG Nowak","year":"2010","unstructured":"Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, et al. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem. 2010;285(8):5532\u201340.","journal-title":"J Biol Chem"},{"issue":"1","key":"3546_CR68","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s11658-024-00622-5","volume":"29","author":"A Wang","year":"2024","unstructured":"Wang A, Zeng Y, Zhang W, Zhao J, Gao L, Li J, et al. N(6)-methyladenosine-modified SRPK1 promotes aerobic Glycolysis of lung adenocarcinoma via PKM splicing. Cell Mol Biol Lett. 2024;29(1):106.","journal-title":"Cell Mol Biol Lett"},{"issue":"48","key":"3546_CR69","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1038\/s41388-024-03189-9","volume":"43","author":"W Lin","year":"2024","unstructured":"Lin W, Xu L, Li Y, Li J, Zhao L. Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing. Oncogene. 2024;43(48):3532\u201344.","journal-title":"Oncogene"},{"issue":"1","key":"3546_CR70","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s42003-020-0983-4","volume":"3","author":"C Wang","year":"2020","unstructured":"Wang C, Zhou Z, Subhramanyam CS, Cao Q, Heng ZSL, Liu W, et al. SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells. Commun Biol. 2020;3(1):268.","journal-title":"Commun Biol"},{"issue":"12","key":"3546_CR71","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1007\/s00262-023-03534-z","volume":"72","author":"M Wahid","year":"2023","unstructured":"Wahid M, Pratoomthai B, Egbuniwe IU, Evans HR, Babaei-Jadidi R, Amartey JO, et al. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of Serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion. Cancer Immunol Immunother. 2023;72(12):4001\u201314.","journal-title":"Cancer Immunol Immunother"},{"issue":"16","key":"3546_CR72","doi-asserted-by":"publisher","first-page":"2000925","DOI":"10.1002\/advs.202000925","volume":"7","author":"WW Xu","year":"2020","unstructured":"Xu WW, Huang ZH, Liao L, Zhang QH, Li JQ, Zheng CC, et al. Direct targeting of CREB1 with imperatorin inhibits TGFbeta2-ERK signaling to suppress esophageal cancer metastasis. Adv Sci (Weinh). 2020;7(16):2000925.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"3546_CR73","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41419-019-1650-x","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Fu Y, Hu X, Sun L, Tang D, Li N, et al. The HBx-CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1. Cell Death Dis. 2019;10(6):405.","journal-title":"Cell Death Dis"},{"key":"3546_CR74","doi-asserted-by":"crossref","unstructured":"Walia MK, Ho PM, Taylor S, Ng AJ, Gupte A, Chalk AM et al. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance. Elife 2016;5.","DOI":"10.7554\/eLife.13446"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03546-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03546-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03546-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T14:05:14Z","timestamp":1760018714000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03546-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3546"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03546-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6969931\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee of Guangzhou Medical University (No. GY2024-387) and conducted under specific pathogen-free conditions in accordance with national guidelines for laboratory animal care and use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and approved the final manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}